Principal Investigators


Endmann

Institution


UCB Pharma GmbH

Contact information of lead PI


Country


Germany

Title of project or programme


Identification and characterization of Novel drug targets in neurodegenerative diseases by RNAi screening

Source of funding information


Federal Ministry of Education and Research (BMBF)

Total sum awarded (Euro)


€ 568,589

Start date of award


01/02/2015

Total duration of award in years


1.9

The project/programme is most relevant to:


Neurodegenerative disease in general

Keywords


Research Abstract


Lay Summary


Further information available at:

Export as PDF